Evidence map›Paper›PMID 40715584›Full record

ArticleJournal of robotic surgery2025

Unveiling predictors of positive surgical margins in Retzius-sparing and anterograde robot-assisted radical prostatectomy: insights from a dual-centre learning curve experience.

Umberto Anceschi, Salvatore Basile, Francesco Prata, Valerio Cellini, Alberto Caviglia, Rocco Simone Flammia, Enrico Vecchio, Elio Mazzone, Gabriele Tuderti, Ofir Maltzman and 15 more

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Journal of robotic surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Umberto AnceschiDepartment of Urology, IRCCS, Regina Elena, National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy.
Salvatore BasileDepartment of Urology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, 200, 00128, Rome, Italy. salvatore.basile@unicampus.it.
Francesco PrataDepartment of Urology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, 200, 00128, Rome, Italy.
Valerio CelliniDepartment of Urology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Alberto CavigliaDepartment of Urology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Rocco Simone FlammiaDepartment of Urology, IRCCS, Regina Elena, National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy.
Enrico VecchioDepartment of Urology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Elio MazzoneDepartment of Urology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Gabriele TudertiDepartment of Urology, IRCCS, Regina Elena, National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy.
Ofir MaltzmanDepartment of Urology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Aldo BrassettiDepartment of Urology, IRCCS, Regina Elena, National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy.
Mariaconsiglia FerrieroDepartment of Urology, IRCCS, Regina Elena, National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy.
Alfredo Maria BoveDepartment of Urology, IRCCS, Regina Elena, National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy.
Riccardo MastroianniDepartment of Urology, IRCCS, Regina Elena, National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy.
Eugenio BolognaDepartment of Urology, IRCCS, Regina Elena, National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy.
Leslie Claire LicariDepartment of Urology, IRCCS, Regina Elena, National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy.
Giuseppe SpadaroDepartment of Urology, IRCCS, Regina Elena, National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy.
Flavia ProiettiDepartment of Urology, IRCCS, Regina Elena, National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy.
Stefano TapperoDepartment of Urology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Dario Di TrapaniDepartment of Urology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Salvatore GuaglianoneDepartment of Urology, IRCCS, Regina Elena, National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy.
Costantino LeonardoDepartment of Urology, IRCCS, Regina Elena, National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy.
Paolo Dell'OglioDepartment of Urology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Antonio GalfanoDepartment of Urology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Giuseppe SimoneDepartment of Urology, IRCCS, Regina Elena, National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Robot-assisted radical prostatectomy (RARP) is a key procedure in urologic surgical training. Both the learning curve and surgical approach may influence the risk of positive surgical margins (PSMs), but evidence from trainee-performed RARP remains limited. This study aimed to identify independent predictors of PSMs in two trainee cohorts using either the Retzius-sparing or anterograde technique under structured mentorship. Two prospectively maintained institutional databases were reviewed for RARP cases performed by five trainees per centre during their first 50 procedures. The patients who underwent pelvic lymph node dissection or had incomplete data were excluded. Cases were stratified by technique: Retzius-sparing (n = 261) and anterograde (n = 276). Baseline and pathological features were compared. Logistic regression was used to identify independent predictors of PSMs for each group. Compared to the Retzius-sparing group, the anterograde cohort had larger prostate volumes (48 vs 42 mL, p = 0.002), higher biopsy core positivity, and more frequent extrafascial dissections (each p < 0.05). In the Retzius-sparing group, performing at least 20 procedures (OR 0.25, p = 0.03) and longer training duration (OR 0.90 per month, p = 0.04) were associated with lower PSMs risk. In the anterograde group, pathological stage ≥ pT3 (OR 3.74, p = 0.02) and prostate volume < 40 mL (OR 0.29, p = 0.04) independently predicted PSMs. Independent predictors of PSMs differed by surgical approach. Surgeon experience and procedure volume reduced PSM risk in Retzius-sparing RARP, whilst pathological stage and prostate size were key factors in the anterograde group. These results may guide trainee selection and case assignment during early robotic training.

Indexed as

Learning CurveMargins of ExcisionOrgan Sparing TreatmentsProstatectomyProstatic NeoplasmsRobotic Surgical ProceduresAgedClinical CompetenceHumansMaleMiddle AgedProstateAnterogradePredictorsPSMsRetzius-sparingTraining

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.